By blocking paracellular phosphate transport, tenapanor added to phosphate binders may improve the hyperphosphatemia management in patients on maintenance dialysis, a study found.
Adding aliskiren to losartan in patients with nondiabetic chronic kidney disease does not result in a greater renal protection and increases their risk of hyperkalemia, a study found.
The proportion of hemodialysis patients with congestive heart failure was 21% for those living below 1000 feet vs 19% and 13% for those living at 1000 to 4000 feet and above 4000 feet, respectively, a study found.
Patients with low BMI had higher mortality risk even at higher spKt/V compared with patients with normal BMI and target range spKt/V of 1.2 to less than 1.4.
In a study of new dialysis patients, low proteinuria was associated with nearly triple the risk for early mortality compared with relatively normal proteinuria.
Patients with CKD who discontinued ACE inhibitors or angiotensin receptor blockers after a hyperkalemia episode had a 2.6-fold increased risk of all-cause mortality compared with patients who continued taking the drugs.